[About the article: "Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis" by Jacobs LD et al].
Labetouelle
M
M
CHU de Bicêtre.
D000276:Adjuvants, Immunologic / Q000008:administration & dosage*; D000284:Administration, Oral; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage; D004311:Double-Blind Method; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006801:Humans; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D016899:Interferon-beta / Q000008:administration & dosage*; D009103:Multiple Sclerosis / Q000150:complications / Q000188:drug therapy*; D009471:Neuromyelitis Optica / Q000188:drug therapy*; D009901:Optic Nerve Diseases / Q000188:drug therapy* / Q000209:etiology; D010919:Placebos; D016032:Randomized Controlled Trials as Topic; D013997:Time Factors
D000276:Adjuvants, Immunologic; D000305:Adrenal Cortex Hormones; D010919:Placebos; D016899:Interferon-beta